ATE551431T1 - Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires - Google Patents

Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires

Info

Publication number
ATE551431T1
ATE551431T1 AT02736798T AT02736798T ATE551431T1 AT E551431 T1 ATE551431 T1 AT E551431T1 AT 02736798 T AT02736798 T AT 02736798T AT 02736798 T AT02736798 T AT 02736798T AT E551431 T1 ATE551431 T1 AT E551431T1
Authority
AT
Austria
Prior art keywords
variable domain
cloning sequences
new method
gene repertoire
immunological
Prior art date
Application number
AT02736798T
Other languages
English (en)
Inventor
Henry Hongjun Ji
Original Assignee
Henry Hongjun Ji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry Hongjun Ji filed Critical Henry Hongjun Ji
Application granted granted Critical
Publication of ATE551431T1 publication Critical patent/ATE551431T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02736798T 2001-05-14 2002-05-14 Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires ATE551431T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29090701P 2001-05-14 2001-05-14
PCT/US2002/015125 WO2002092770A2 (en) 2001-05-14 2002-05-14 Novel method for cloning variable domain sequences of immunological gene repertoire

Publications (1)

Publication Number Publication Date
ATE551431T1 true ATE551431T1 (de) 2012-04-15

Family

ID=23117996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736798T ATE551431T1 (de) 2001-05-14 2002-05-14 Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires

Country Status (4)

Country Link
EP (1) EP1392866B1 (de)
AT (1) ATE551431T1 (de)
CA (1) CA2450217A1 (de)
WO (1) WO2002092770A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3491384B1 (de) * 2016-08-01 2021-06-09 Health Research, Inc. Zusammensetzungen und verfahren zum schnellen klonen von t-zell-rezeptoren
US11001868B2 (en) * 2017-08-11 2021-05-11 Global Life Sciences Solutions Operations UK Ltd Cell-free protein expression using double-stranded concatameric DNA

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512463A (en) * 1991-04-26 1996-04-30 Eli Lilly And Company Enzymatic inverse polymerase chain reaction library mutagenesis
US6107059A (en) * 1992-04-29 2000-08-22 Affymax Technologies N.V. Peptide library and screening method
WO1994011507A2 (en) * 1992-11-19 1994-05-26 Gingeras Thomas R Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna
US5834252A (en) * 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
CA2185239C (en) * 1994-03-16 2002-12-17 Nanibhushan Dattagupta Isothermal strand displacement nucleic acid amplification
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
CA2342838A1 (en) * 1998-09-15 2000-03-23 Yale University Molecular cloning using rolling circle amplification
AU4332399A (en) * 1999-06-04 2000-12-28 Cheng-Ming Chuong Rna polymerase chain reaction
CA2436693A1 (en) * 2000-12-11 2002-06-20 Alexion Pharmaceuticals, Inc. Nested oligonucleotides containing hairpin for nucleic acid amplification

Also Published As

Publication number Publication date
EP1392866A2 (de) 2004-03-03
EP1392866A4 (de) 2004-12-22
EP1392866B1 (de) 2012-03-28
WO2002092770A3 (en) 2003-05-22
WO2002092770A2 (en) 2002-11-21
CA2450217A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
SG142330A1 (en) Anti-cd38 human antibodies and uses therefor
EP4283295A3 (de) Rekombinante polyklonale proteine und verfahren zur verwendung davon
DK0937140T3 (da) Antistofmolekyler, som interagerer specifikt med et målmolekyles aktive sted eller klöft
UA95438C2 (ru) Биспецифические антитела, которые замещают функциональные белки
PL374311A1 (en) Methods for purifying protein
DE60234464D1 (de) Zusammensetzungen und Verfahren zur selektiven Nukleinsäureisolierung
DE602006021324D1 (de) Verfahren zur herstellung stabiler b-lymphozyten
DK1809663T3 (da) Fremgangsmåde til oprensning af FSH
PT2305715T (pt) Anticorpo monoclonal para a proteína de ligação a osteoprotegerina
DE60232083D1 (de) Expansionskulturverfahren für antigenspezifische zytotoxische t-lymphozyten
EA200600459A1 (ru) Способ получения цитотоксических лимфоцитов
MX2009005160A (es) Plantas que tienen rasgos relacionados con rendimiento mejorados y un metodo para hacer las mismas usando secuencias de consenso de la familia de proteina y abby.
ATE489478T1 (de) Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation
ATE539085T1 (de) Verfahren zur isolierung von haptoglobin
ATE269900T1 (de) Verfahren zur molekularen evolution der antikörperfunktion
DE60210087D1 (de) Verfahren zur standzeitverlängerung eines hydro-oxidationskatalysators
ATE551431T1 (de) Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires
DE60332600D1 (de) Selektive elution von immobilisierten multiplexierten primerverlängerungsprodukten
ATE318279T1 (de) Verfahren zur herstellung von organomodifizierten polysiloxanen unter verwendung ionischer flüssigkeiten
DE50307968D1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen
DK1396501T3 (da) Antistoffer til identifikation og/eller isolering af mindst én cellepopulation, der er valgt fra gruppen omfattende haematopoietiske stamceller, neuronale stamceller, neuronale precursorceller, mesenchymale stamceller og mesenchymale precursorceller
ATE346084T1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
ATE402948T1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
DK1297123T3 (da) Fremgangsmåde til genomudvinding af sekreterede proteingener
WO2023076420A3 (en) Multispecific sars-cov-2 antibodies and methods of use